Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Phase 3 Terminated 89 enrolled SK Life Science, Inc.

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this research study is to compare the long term effectiveness, safety and tolerability of carisbamate compared to two other frequently prescribed anti-epileptic drugs (AEDs) in patients with epilepsy.

Timeline

Start: 2007-11
Primary completion: 2010-04
Completion: 2010-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Carisbamate	Small molecule	800 mg	Oral
Comparator	Levetiracetam	Other / unclassified	2000 mg	Oral
Comparator	Topiramate	Small molecule	300 mg	Oral

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Summary

Timeline

Drugs

Indications